KFC is switching from PepsiCo to Coca-Cola across its US restaurants, marking a major change in the fast-food beverage business.
BUSINESS
Is AI Deciding Your Big Mac Price? McDonald Sued Over AI-Price Fixing
McDonald’s is facing a proposed US class action over alleged AI-driven price coordination. The case raises important questions for founders using AI to set or recommend prices.
Popular Reads
Category . Author
Story
Business
Honda’s Next Big Move: A $2.5B Hybrid Plant in Ohio
Honda plans to invest up to $2.53 billion in a new hybrid vehicle production plant in Ohio, with production expected to start in 2030.
Business
Sydney Sweeney’s New Business Model: Why Her Biggest Paydays May No Longer Come From Acting
Sydney Sweeney is building a business portfolio beyond acting, with Fifty-Fifty Films, SYRN, major brand deals and a Novig equity partnership creating new ways for the actress to participate in long-term business value.
Business
Novo Nordisk Open to New York Listing as US Market Gains Importance
Novo Nordisk is open to a direct New York Stock Exchange listing, CEO Mike Doustdar told the Financial Times, although the Wegovy and Ozempic maker is not currently exploring the move.
Business
UK Employers’ Pay Awards Cool to 3% as Labor Market Softens
UK pay awards have cooled to 3%, with Brightmine data showing employers are keeping salary increases subdued as higher employment costs, tighter budgets and a softer labor market shape pay decisions heading into 2027.
More business News
01
ACCC Again Blocks IAG’s RAC Insurance Deal Over Competition Concerns
The ACCC has again blocked IAG’s proposed acquisition of RAC Insurance, warning that the deal would substantially reduce competition in Western Australia’s motor and home insurance markets and significantly increase IAG’s market share.
02
ASIC Private Credit Warning: How Funds Can Respond to Rising Valuation and Lending Risks
ASIC is increasing scrutiny of private credit funds, focusing on valuations, disclosure, governance and lending controls following market stress.
03
Nvidia’s AI Play Gets a Biotech Twist as Iambic Files for IPO
Iambic Therapeutics filed for a Nasdaq IPO after raising $461.8 million. The company reported $2.9 million collaboration revenue, a $48.4 million net loss and $427.3 million in cash, while its lead cancer programme remains in Phase 1/1b trials.